Trial intelligence / Profile preview

Sulindac and VSL#3/Inulin for Adenoma Prevention in FAP Pouch

NCT00319007Phase 2Unknown

Sponsor
Radboud University Medical Center
Start
Apr 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sulindac in familial adenomatous polyposis (FAP), sponsored by Radboud University Medical Center. Status: unknown.

02

Drugs

sulindac
03

Conditions

familial adenomatous polyposis (FAP)

Beyond the preview

Go deeper on NCT00319007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00319007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call